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Abstract
Objective Pyloric stenosis (PS) is rare in the first 2 weeks
of life, often leading to delays in diagnosis and treatment.
We conducted a case control study to delineate the char-
acteristics of patients with early PS (EPS). In addition, we
tested the hypothesis that patients with EPS present with a
smaller pylorus than older patients.
Methods A database of all patients presenting with PS to
a children’s hospital over a 5-year period (2002–2006) was
obtained. Each patient admitted during the first 2 weeks of
life (subject) was matched to a patient admitted after
4 weeks of age (control), with the same gender, electrolyte
status, and treating surgeon. A single pediatric radiologist,
blinded to patient age, reviewed all available ultrasounds
retrospectively. Demographic, clinical, diagnostic, thera-
peutic, and outcome data were compared.
Results During the study period, 278 pyloromyotomies
were performed for PS. Sixteen patients (5.8%) presented
with EPS between 2 and 14 days of life. EPS patients had a
higher prevalence of positive family history (31 vs. 0%,
P = 0.043), and breast milk feeding (75 vs. 31%,
P = 0.045). Sonographic measurements showed a pylorus
that was of significantly less length (17.1 ± 0.6 vs.
20.5 ± 0.9 mm, P = 0.006) and muscle thickness (3.5 ±
0.2 vs. 4.9 ± 0.2 mm, P \ 0.001) in patients with EPS.
Hospital stay was significantly longer for EPS patients
(4.3 ± 0.9 vs. 2.0 ± 0.1 days, P = 0.19)
Conclusions Babies presenting with EPS are more likely
to be breast fed and to have a positive family history. EPS
is associated with a longer hospital stay. Use of sono-
graphic diagnostic measurements specific to this age group
may prevent delays in diagnosis and treatment, and
improve outcomes.
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Introduction
Infantile hypertrophic pyloric stenosis (PS), first described
by Hirschsprung [1], occurs in approximately 3 of every
1,000 livebirths [2], making it the most common indication
for surgical intervention in infancy. It is characterized by
hypertrophy and thickening of the circular and longitudinal
muscle of the pylorus, leading to a gastric outlet obstruc-
tion. The typical presentation is projectile, non-bilious
vomiting occurring between 3 weeks and 3 months of age.
Failure to diagnose the condition often results in weight
loss, dehydration, and metabolic abnormalities. In experi-
enced hands, the clinical diagnosis can be made by
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palpation of the thickened pylorus, or ‘‘olive’’, in the right
upper quadrant. However, in the twenty-first century, this
has been largely replaced by sonographic diagnosis [3].
Sonographic diagnostic criteria include a muscle thickness
of at least 3–4 mm and a pyloric channel length of at least
14–17 mm [3–13]. However, there is no consensus on
whether these measurements are influenced by age, size, or
prematurity [5–10, 12, 13]. There are also no defined
parameters for diagnostic measurements in the youngest
patients, those presenting in the first 2 weeks of life. This,
in addition to the perception that PS is rare in the first
2 weeks of life, often leads to symptom misinterpretation,
further diagnostic imaging, and delayed diagnosis.
To our knowledge, there are no reports in the literature
on patients with early pyloric stenosis (EPS), which we
defined as those presenting in the first 2 weeks of life. We
conducted a case–control study of these patients, to
delineate their demographic, clinical, therapeutic, and
outcome characteristics. In addition, we tested the
hypothesis that patients with EPS present with a smaller
pylorus than their older counterparts.
Patients and methods
The study was performed at Miller Children’s Hospital,
Long Beach, California. The hospital is affiliated with the
University of California, Irvine School of Medicine and
serves as the pediatric tertiary care institution for the
greater Long Beach, northern Orange County, and southern
Los Angeles County regions. A database of all the patients
presenting with PS during a 5-year period (2002–2006) was
obtained from the hospital medical records department
using ICD-9 code 750.5 (congenital pyloric stenosis), and
CPT code 43520 (pyloromyotomy). Each patient diagnosed
with pyloric stenosis during the first 14 days of life (sub-
ject, EPS) was matched to a patient diagnosed after 30 days
of age (control, PS). Matching was controlled for gender,
electrolyte status, and treating surgeon. Other than the three
matching criteria, no data were known or collected prior to
initiating the chart reviews.
All pyloromyotomies during the study period were
performed by three board-certified pediatric surgeons. One
surgeon used a right upper quadrant approach, a second
used a peri-umbilical approach, and the third initially used
a peri-umbilical approach, but switched to a laparoscopic
approach in late 2005. Approximately half the patients
were transferred from outside institutions with a pre-
sumptive diagnosis of pyloric stenosis. In those cases,
initial imaging was completed at the referring facility, and
sent with the patient. Sonograms performed at Miller
Children’s Hospital were initially read by pediatric or
general, radiologists. However, in the study design, a single
pediatric radiologist (SN), blinded to patient age, reviewed
all available ultrasounds retrospectively.
Demographic, clinical, diagnostic, therapeutic, and
outcome data were compared between the two groups by t
tests, or Fisher’s exact test, as appropriate. A P value\0.05
was considered significant. Continuous data are reported at
mean ± standard error of the mean. The study was
approved by the Memorial Health Services Institutional
Review Board (400-06CR).
Results
During the study period, 278 pyloromyotomies were
performed for PS. Sixteen patients (5.8%) presented with
EPS between 2 and 14 days of life. Average age was
11.3 ± 0.8 days for subjects and 42.8 ± 3.1 days for
controls. In each group, 86% were males, and 13% pre-
sented with metabolic alkalosis. There were no significant
differences in any of the demographic data (Table 1). The
clinical characteristics data is shown in Table 2. EPS
patients had a significantly higher prevalence of positive
family history (5 patients, 31%). Three patients had an
affected parent and 2 patients had an affected sibling. The
prevalence of breast milk feeding was also significantly
higher in EPS patients (12 patients, 75%). Nine of the
twelve patients were fed a combination of formula and
breast milk, while three were fed exclusively breast milk.
Ultrasound was the first imaging test performed in 81%
of subjects and controls alike. Upper gastrointestinal study
Table 1 Demographics
EPS PS P
N = 16 N = 16
Firstborn (%) 63 69 NS
Premature (%) 6 13 NS
C/section delivery (%) 38 44 NS
Gestational age (weeks) 39.6 ± 0.4 38.8 ± 0.4 NS
Gestational weight (grams) 3555 ± 141 3178 ± 194 NS
EPS early pyloric stenosis, PS pyloric stenosis, NS not significant
Table 2 Clinical characteristics
EPS PS P
N = 16 N = 16
Positive family history (%) 31 0 0.043
Breast milk feeding (%) 75 31 0.045
Duration of emesis (%) 3.1 ± 0.5 13.5 ± 3.3 0.004
Projectile emesis (%) 88 94 NS
Co-morbidities (%) 12 12 NS
Weight (grams) 3459 ± 120 4049 ± 156 NS
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(UGI) was the first test in 3 patients in each group. All the
patients eventually received at least one US during the
work-up. US was diagnostic in 50% of subjects and 81% of
controls, P = 0.06. Repeat US and/or UGI was employed to
establish the diagnosis in the remainder. Ultrasounds were
available for blinded retrospective review for 11 subjects
and 13 controls. Sonographic measurements showed sig-
nificantly shorter and thinner pylori in patients with EPS
versus their older counterparts (Table 3). Sonographic
shouldering was seen in 73% of subjects and 92% of con-
trols. The difference was not statistically significant. Failure
to pass gastric contents was noted on all ultrasounds.
Therapeutic and outcome data are shown in Table 4.
Despite a similar incidence of metabolic alkalosis in the two
groups, duration between admission and operation was sig-
nificantly longer for subjects. The longer duration to full feeds
in subjects did not reach statistical significance. However,
duration between operation and discharge, and total hospital
stay were significantly longer in subjects. One subject,
operated through a peri-umbilical incision at 9 days of age,
developed a wound infection and positive S. aureus blood
cultures, requiring 10 days of intravenous antibiotics and 13-
day hospitalization. There were no other complications.
Discussion
Congenital hypertrophic pyloric stenosis is the most com-
mon etiology of infantile intestinal obstruction, occurring
in 2–5/1,000 live births per year [2, 3]. The overwhelming
majority of patients ([95%) present between 3 and
12 weeks after birth [2]. However, reports have docu-
mented cases of early onset PS, including presentation at
birth [14, 15]. In addition, there is evidence that the age at
which PS is diagnosed is steadily decreasing [16]. This
trend was evident, even before the introduction of ultra-
sound, signifying a possible epidemiologic shift in age at
presentation [16]. In our study, 6% of the patients pre-
sented in the first 2 weeks of life, a rate twice that found in
a large epidemiologic study from California published a
decade ago [2].
Early presentation, occurring during the first 14 days of
life, presents the clinician with several challenges. First,
the symptoms are often confused with gastroesophageal
reflux, an almost ubiquitous condition in the first 2 weeks
of life. Second, the clinical impression that PS is unlikely
to present early often adds to delay in diagnosis. Finally,
the lack of established sonographic criteria for the
smallest patients commonly produces equivocal imaging
results.
Our study was designed to elucidate the epidemiologic,
clinical, diagnostic, and outcome characteristics of patients
with EPS through a case control design, eliminating the
major confounding factors of electrolyte imbalance, sur-
gical approach, and treating clinician. Our results show that
early presenting patients are more likely to have a positive
family history than older patients. Almost 1 in 3 patients
with EPS has an affected first-degree relative. This dupli-
cates the finding of the only other study in the literature on
early presenting pyloric stenosis, where patients younger
than 21 days were found to have a 32% prevalence of
positive family history versus 8% prevalence in older
infants [17]. Anecdotally, we discovered that the parents
and siblings of our subjects with positive family history
presented at approximately the same age as the probands.
The etiology of PS, still mysterious, undoubtedly includes
genetic and environmental components [18–21]. In an
elegant, prospective study, Rollins et al. [21] demonstrated
that, in a population of 1,400 infants, none of the nine
patients who subsequently developed PS had an abnormal
pylorus at birth. It appears that genetics may play a
stronger role in the etiology of EPS.
Another remarkable finding in our study is the signifi-
cantly higher prevalence of breast milk feeding in EPS
patients. To our knowledge, the only other report of
potential association between breast milk and PS comes
from an Italian report of two cases [22]. Davanzo et al. [22]
postulated that cow’s milk protein allergy, transmitted
through breast milk, was an etiologic factor in two babies
with PS. To the contrary, although not statistically ana-
lyzed, Zhang et al. [23] found a lower prevalence of breast
feeding in PS patients.
Table 3 Sonographic measurements
EPS PS P
N = 11 N = 13
Longitudinal view
Pyloric channel length (mm) 17.1 ± 0.6 20.5 ± 0.9 0.006
Range 15.0–20.0 14.6–27.0
Pyloric wall thickness (mm) 3.5 ± 0.2 4.9 ± 0.2 \0.001
Range 2.7–4.5 3.7–5.9
Cross-sectional view
Pyloric wall thickness (mm) 2.8 ± 0.2 4.6 ± 0.2 \0.001
Range 2.0–3.5 3.5–6.0
Table 4 Therapeutic and outcome data
EPS PS P
N = 16 N = 16
Admission to operation (days) 1.1 ± 0.2 0.6 ± 0.1 0.047
Operation to full feeds (days) 2.1 ± 0.4 1.4 ± 0.1 NS
Operation to discharge (days) 3.4 ± 0.8 1.4 ± 0.1 0.015
Hospital stay (days) 4.3 ± 0.9 2.0 ± 0.1 NS
Complications (%) 6 0 NS
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In 1977, Teele and Smith [24] published the first report
on the utility of US in the diagnosis of PS. Since then, the
speed, facility, safety, and non-invasiveness of US have
established it as the test of choice for the diagnosis of PS.
In our region, few radiologists use the UGI study to eval-
uate possible PS. Rather, the UGI is used following
equivocal ultrasound results, or when gastroesophageal
reflux is the suspected etiology for emesis. Approximately
one-third of EPS patients in our study received an UGI, not
significantly higher than the control group, but three times
as high as our overall PS population (\10%). Four of the
five UGI studies in the EPS group were performed as the
first imaging modality because the assessing clinician felt
the child was too young to have PS (2, 12, 13, and
13 days). In those 4 patients, ultrasounds were performed
after the UGI, and 3 were still interpreted as equivocal
despite the positive UGI. The fifth was performed after an
equivocal ultrasound in a 12-day-old baby. Interestingly,
the prevalence of projectile emesis was not significantly
lower in EPS patients, establishing the symptom as a
reliable predictor of PS in all age groups.
There has been significant controversy in the literature
regarding what measurements of pyloric muscle thickness
(PMT) and pyloric muscle length (PML) are consistent
with PS [3–13]. The most accepted measurements con-
firming PS are a PMT C 4 mm, and a PML C 17 mm, but
threshold PMT and PML vary between 3.0–4.5 mm and
14–20 mm, respectively [3]. Accepting the lower limits
may increase the false positive rate, while accepting the
higher ones may increase the false negative rate. In one of
the earlier reports, dell’Agnola et al. [4] alluded to the
notion that younger babies may have less thickened mus-
cle, although their study did not include any patients
younger than 3 weeks. Kofoed et al. [5] concluded that no
correlation with age and weight exist, but again did not
study the youngest patients. In one of the few studies
looking at younger patients, Lamki et al. [7] found that
PMT was significantly less in children less than 30 days
old, but there was no difference in PML. They suggested a
diagnostic PMT value of 3 mm in children less than
1 month of age [7]. Hernanz-Schulman et al. [8] agreed
with this finding, and again set a lower limit of 3 mm for
PMT. However, they did not investigate any patients less
than 2 weeks of age [8]. Haider et al. [10] found that
decreased PMT was strongly correlated with weight, but
not age. Most recently, Australian investigators added to
the controversy by reporting no significant correlation
between sonographic measurements and age, weight, or
prematurity [13]. They recommended using the same cri-
teria (PMT C 3 mm and PML C 17 mm) for all the
patients [13]. However, once again, age data were not
clearly reported in the study [13].
Noticing a significant decrease in the age of the patients
presenting to our service with PS over the last 10 years,
and frequent difficulty in making a sonographic diagnosis
in the youngest patients, we concentrated our study on
patients presenting in the first 2 weeks of life. We
hypothesized that EPS patients have shorter and thinner
pylori than their older counterparts. Our study demon-
strated that, after blinded retrospective review of the ul-
trasounds, EPS patients had significantly decreased PMT
and PML measurements, confirming our hypothesis. When
the PMT was measured longitudinally, all but two of the
eleven EPS patients whose ultrasounds were available for
review had values less than 4 mm. In the cross-sectional
view, 7 of the 11 patients had PMT values less than 3 mm,
and none reached the 4-mm threshold. In the control group,
cross sectional and longitudinal PMT measurements were
consistent. We believe that, in EPS, the pylorus may be
heterogeneous in thickness, and cross-sectional measure-
ments may represent false sampling. Therefore, we rec-
ommend the pyloric muscle be always measured at the
thickest point in the longitudinal view. Although shoul-
dering was not universally demonstrated, all patients
showed failure to pass a gastric feed. This emphasizes a
conclusion from a comprehensive review by Hernanz-
Schulman [3]. ‘‘The actual numeric value is less important
than the overall morphology of the canal and the real-time
observations.’’ [3] Ultrasound, therefore, should remain the
imaging modality of choice for patients, of any age, sus-
pected of having PS. We feel it would be advantageous for
an experienced pediatric radiologist to perform the ultra-
sound for patients presenting early, whenever possible.
In the setting of projectile or persistent emesis in a
baby less than 2 weeks old, the sonographic triad of
PMT C 2.5 mm, PML C 14 mm, and failure to pass gas-
tric contents is diagnostic of PS. Palpation should always
remain an important part of the clinician’s armamentarium,
and in fact can resolve the diagnostic dilemma arising from
equivocal imaging. UGI studies should be rarely required,
if at all.
We found that EPS patients spent approximately twice
as much time in the hospital before proceeding to opera-
tion, despite controlling for metabolic alkalosis in the
analysis. Although difficult to ascertain, the delay was most
likely due to the diagnostic dilemmas in this age group. We
also found a significantly increased duration between
operation and discharge, as well as overall longer hospital
stay in the youngest patients, despite no significant statis-
tical difference in the period required to achieve full feeds.
This persisted after excluding the EPS patient with wound
infection and bacteremia from the analysis, and likely
represents clinicians’ reluctance to discharge these neo-
nates early. Despite this, all PS patients in our study,
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regardless of age, had the expected excellent outcomes
associated with this disease.
Our study has some obvious limitations. Since the
numbers of subjects and controls are small, differences in
positive family history and incidence of breast milk feeding
may not have been significant if a few more patients in the
control group had a positive family history or were breast
fed. A case control design was chosen to minimize con-
founding variables with respect to outcome measurements,
but had little effect on epidemiologic and diagnostic
parameters. The latter may have been better analyzed
through comparing patients with EPS to the rest of the
patients. However, we did not believe that comparing 16
patients to 262 would have been statistically sound. Ul-
trasounds were available for blinded review for the
majority of patients, but not all. Although this may have
caused some alterations in the average pyloric measure-
ments, it is unlikely to have led to different conclusions,
given the narrow standard errors and high statistical
significance.
Conclusions
In this pilot study of patients presenting with pyloric stenosis
during the first 2 weeks of life, we found an increase in
genetic predisposition and breast milk feeding. We also
demonstrated that the pylori in these patients, although
stenotic, often do not meet the accepted sonographic criteria
for patients in the typical age range. Recognizing that PS can
present very early, performing a careful history and physical
examination, and employing a sonographic triad of longi-
tudinal muscle thickness C2.5 mm, muscle length C14 mm,
and gastric outlet obstruction, can achieve a prompt diag-
nosis, avoid unnecessary additional imaging, and improve
outcomes in patients with EPS. The findings noted here can
be further confirmed through a properly designed prospec-
tive study that attempts to correlate age and weight with
epidemiologic and sonographic parameters.
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